Furosemide 40 Biotech 40 mg Capsules
PDF Leaflet Revision Date: 16 November 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of oedema of cardiac, hepatic or renal origin.
Dosage (summary)
40 mg daily, may increase to 80 mg or 120 mg if no response; maintenance 20-40 mg daily.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not to be used in the first trimester; contraindicated in lactation.
Key Drug Interactions
- Antihypertensives
- ACE inhibitors
- Antipsychotics
- Cardiac glycosides
- NSAIDs
Contraindications
- Hypersensitivity to furosemide
- Severe renal disease
- Hypokalaemia
- Hepatic coma
Common side effects
- Hypotension
- Dehydration
- Hyponatraemia
- Dizziness
- Tinnitus
Counselling Points
- Monitor blood pressure
- Stay hydrated
- Report any hearing changes
- Avoid alcohol
Serious warnings
- Risk of hypotension
- Electrolyte imbalances
- Ototoxicity risk
Important Disclaimer
The Furosemide 40 Biotech 40 mg Capsules professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
